Explore This Research Lab
Cardiovascular disease, largely due to coronary artery disease, is the leading cause of death in the U.S. and worldwide.
The Natarajan Laboratory at Massachusetts General Hospital uses genomics, biomarkers, bioinformatics, mobile technology, and deep phenotypic learning to discover and understand the causal factors of atherosclerotic cardiovascular disease across diverse populations. These insights are implemented into prospective studies to improve cardiovascular care.
The lab spans the Massachusetts General Hospital Cardiovascular Research Center and Center for Genomic Medicine, Program in Medical & Population Genetics of the Broad Institute of Harvard and MIT, and Harvard Medical School.
For details about our work, including publications, available research positions, and more information for patients, please visit the Natarajan Lab’s main website.
See all publications >
Meet Our Team
Pradeep Natarajan, MD, MMSc, Principal Investigator and Director of Preventive Cardiology at Massachusetts General Hospital, where he oversees prevention, genetics, and cardiac rehabilitation programs for atherosclerotic cardiovascular disease.
Phoebe Finneran, BS, Clinical Research Coordinator
Akhil Pampana, MS, Computational Biologist
Maryam Zekavat, BS, Yale MD/PhD Student